U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 366

1.
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T. Johnson, Santosha Vardhana, Maria Arcila, Steven M. Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao
Blood Adv. 2024 Jun 25; 8(12): 3064–3075. Published online 2024 Apr 10. doi: 10.1182/bloodadvances.2023011733
PMCID:
PMC11222957
AbstractArticlePDF–2.9M
2.
Soluble Fas in malignant pleural effusion and its expression in lung cancer cells
Kayo Mitani, Yasuhiko Nishioka, Kazue Yamabe, Hirohisa Ogawa, Toyokazu Miki, Hiroaki Yanagawa, Saburo Sone
Cancer Sci. 2003 Mar; 94(3): 302–307. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2003.tb01437.x
PMCID:
PMC11160079
AbstractArticlePDF–199K
3.
CD95-mediated cell signaling in cancer: mutations and post-translational modulations
Sébastien Tauzin, Laure Debure, Jean-François Moreau, Patrick Legembre
Cell Mol Life Sci. 2012 Apr; 69(8): 1261–1277. Published online 2011 Nov 1. doi: 10.1007/s00018-011-0866-4
PMCID:
PMC11115069
AbstractArticlePDF–613K
4.
Glycemic Index, Glycemic Load, and FAS rs6586161 Polymorphism in Relation to Gastric Cancer Risk: A Case-Control Study in Korea
Hong Kyoung Kim, Sang Young Kim, Jung Hyun Kwak, Hyun Ja Kim
Nutrients. 2023 Jul; 15(14): 3238. Published online 2023 Jul 21. doi: 10.3390/nu15143238
PMCID:
PMC10383319
AbstractArticlePDF–255K
5.
Single nucleotide variant in FAS associates with organ failure and soluble Fas in critical illness
Carmen Mikacenic, Pavan Bhatraju, Cassianne Robinson-Cohen, Susanna Kosamo, Alison E. Fohner, Victoria Dmyterko, S. Alice Long, Karen Cerosaletti, Carolyn S. Calfee, Michael A. Matthay, Keith R. Walley, James A. Russell, Jason D. Christie, Nuala J. Meyer, David C. Christiani, Mark M. Wurfel
Crit Care Med. Author manuscript; available in PMC 2023 Mar 1.
Published in final edited form as: Crit Care Med. 2022 Mar 1; 50(3): e284–e293. doi: 10.1097/CCM.0000000000005333
PMCID:
PMC8863632
AbstractArticlePDF–750K
6.
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies
Filippo Consonni, Eleonora Gambineri, Claudio Favre
Ann Hematol. 2022; 101(3): 469–484. Published online 2022 Jan 20. doi: 10.1007/s00277-022-04761-7
PMCID:
PMC8810460
AbstractArticlePDF–3.2M
7.
The genetic landscape of the FAS pathway deficiencies
Aude Magerus, Clara Bercher-Brayer, Frédéric Rieux-Laucat
Biomed J. 2021 Aug; 44(4): 388–399. Published online 2021 Jun 24. doi: 10.1016/j.bj.2021.06.005
PMCID:
PMC8514852
AbstractArticlePDF–1.5M
8.
Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome
Marta López-Nevado, Jorge Docampo-Cordeiro, José T. Ramos, Rebeca Rodríguez-Pena, Celia Gil-López, Silvia Sánchez-Ramón, Juana Gil-Herrera, María J. Díaz-Madroñero, María A. Delgado-Martín, Pablo Morales-Pérez, Estela Paz-Artal, Aude Magerus, Frederic Rieux-Laucat, Luis M. Allende
Front Immunol. 2021; 12: 656356. Published online 2021 Apr 29. doi: 10.3389/fimmu.2021.656356
PMCID:
PMC8117005
AbstractArticlePDF–2.3M
9.
Soluble Fas affects erythropoiesis in vitro and acts as a potential predictor of erythropoiesis-stimulating agent therapy in patients with chronic kidney disease
Daniela Mendes Chiloff, Danilo Candido de Almeida, Maria A. Dalboni, Maria Eugênia Canziani, Sunil K. George, Alshaimaa Mahmoud Morsi, Nadia El-Akabawy, Christopher D. Porada, Marcelino Souza Durao, Abolfazl Zarjou, Graca Almeida-Porada, Miguel Angelo Goes
Am J Physiol Renal Physiol. 2020 Apr 1; 318(4): F861–F869. Published online 2020 Jan 31. doi: 10.1152/ajprenal.00433.2019
PMCID:
PMC7474254
AbstractArticle
10.
The role of FAS gene variants in inflammatory bowel disease
Ayhan Demir, Resul Kahraman, Gonca Candan, Arzu Ergen
Turk J Gastroenterol. 2020 May; 31(5): 356–361. Published online 2020 May 1. doi: 10.5152/tjg.2020.19436
PMCID:
PMC7289171
AbstractArticlePDF–147K
11.
The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
Abdul S. Qadir, Austin M. Stults, Andrea E. Murmann, Marcus E. Peter
Sci Rep. 2020; 10: 1310. Published online 2020 Jan 28. doi: 10.1038/s41598-020-58211-3
PMCID:
PMC6987111
AbstractArticlePDF–7.7M
12.
Association between FAS gene −670 A/G and −1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis
Hongwei Yan, Yuxiao Hong, Yunfei Cai
Biosci Rep. 2020 Jan 31; 40(1): BSR20191197. Published online 2020 Jan 6. doi: 10.1042/BSR20191197
PMCID:
PMC6944657
AbstractArticlePDF–914K
13.
Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia
Ying Chen, Hanfei Wang, Yunwen Yan, Min Ren, Cunye Yan, Benzhong Wang
Medicine (Baltimore) 2019 Dec; 98(49): e18240. Published online 2019 Dec 10. doi: 10.1097/MD.0000000000018240
PMCID:
PMC6919540
AbstractArticlePDF–521K
14.
Apoptosis in human embryo development: 3. Fas‐induced apoptosis in brian primary cultures
Roxana Nat, E. Radu, T. Regalia, L. M. Popescu
J Cell Mol Med. 2001 Oct; 5(4): 417–428. Published online 2007 May 1. doi: 10.1111/j.1582-4934.2001.tb00177.x
PMCID:
PMC6740267
AbstractArticlePDF–3.9M
15.
Apoptosis in the immune system: 1. Fas‐induced apoptosis in monocytes‐derived human dendritic cells
Roxana Nat, E. Radu, T. Regalia, L. M. Popescu
J Cell Mol Med. 2002 Apr; 6(2): 223–234. Published online 2007 May 1. doi: 10.1111/j.1582-4934.2002.tb00189.x
PMCID:
PMC6740210
AbstractArticlePDF–2.4M
16.
Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Yingying Shen, Zhengbo Song, Xinliang Lu, Zeyu Ma, Chaojie Lu, Bei Zhang, Yinghu Chen, Meng Duan, Lionel Apetoh, Xu Li, Jufeng Guo, Ying Miao, Gensheng Zhang, Diya Yang, Zhijian Cai, Jianli Wang
Nat Commun. 2019; 10: 2924. Published online 2019 Jul 2. doi: 10.1038/s41467-019-10889-4
PMCID:
PMC6606754
AbstractArticlePDF–2.6M
17.
Cell polarity and adherens junction formation inhibit epithelial Fas cell death receptor signaling
Laurent Gagnoux-Palacios, Hala Awina, Stéphane Audebert, Aurélie Rossin, Magali Mondin, Franck Borgese, Carlota Planas-Botey, Amel Mettouchi, Jean-Paul Borg, Anne-Odile Hueber
J Cell Biol. 2018 Nov 5; 217(11): 3839–3852. doi: 10.1083/jcb.201805071
PMCID:
PMC6219722
AbstractArticlePDF–3.0M
18.
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis
Haiwei Mou, Jill Moore, Sunil K. Malonia, Yingxiang Li, Deniz M. Ozata, Soren Hough, Chun-Qing Song, Jordan L. Smith, Andrew Fischer, Zhiping Weng, Michael R. Green, Wen Xue
Proc Natl Acad Sci U S A. 2017 Apr 4; 114(14): 3648–3653. Published online 2017 Mar 20. doi: 10.1073/pnas.1620861114
PMCID:
PMC5389295
AbstractArticlePDF–1.3M
19.
CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage
Danielle A Raats, Nicola Frenkel, Susanne J van Schelven, Inne HMBorel Rinkes, Jamila Laoukili, Onno Kranenburg
Cell Death Dis. 2017 Mar; 8(3): e2669. Published online 2017 Mar 16. doi: 10.1038/cddis.2017.87
PMCID:
PMC5386578
AbstractArticlePDF–2.9M
20.
Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
Erik J. Blok, Jitske van den Bulk, N. Geeske Dekker-Ensink, Remco Derr, Corné Kanters, Esther Bastiaannet, Judith R. Kroep, Cornelis J.H. van de Velde, Peter J.K. Kuppen
Oncotarget. 2017 Feb 28; 8(9): 15610–15620. Published online 2017 Jan 21. doi: 10.18632/oncotarget.14779
PMCID:
PMC5362509
AbstractArticlePDF–2.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center